These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 38563451)
1. Effect of a Declined Plasma Concentration of Valproic Acid Induced by Meropenem on the Antiepileptic Efficacy of Valproic Acid. Gu C; Zhang Y; Yuan F; Huang K; Lin Z; Chen Q; Chen Y; Wu Y; Wang D; Wang S J Clin Lab Anal; 2024 Apr; 38(8):e25025. PubMed ID: 38563451 [TBL] [Abstract][Full Text] [Related]
2. Drug-drug interaction between valproic acid and meropenem: a retrospective analysis of electronic medical records from neurosurgery inpatients. Wen ZP; Fan SS; Du C; Yin T; Zhou BT; Peng ZF; Xie YY; Zhang W; Chen Y; Xiao J; Chen XP J Clin Pharm Ther; 2017 Apr; 42(2):221-227. PubMed ID: 28145574 [TBL] [Abstract][Full Text] [Related]
3. [Seven cases of decreased serum valproic acid concentration during concomitant use of carbapenem antibiotics]. Lee SG; Kim JH; Joo JY; Kwon OH Korean J Lab Med; 2007 Oct; 27(5):338-43. PubMed ID: 18094598 [TBL] [Abstract][Full Text] [Related]
4. Pharmacological interaction between valproic acid and carbapenem: what about levels in pediatrics? Miranda Herrero MC; Alcaraz Romero AJ; Escudero Vilaplana V; Fernández Lafever SN; Fernández-Llamazares CM; Barredo Valderrama E; Vázquez López M; de Castro P Eur J Paediatr Neurol; 2015 Mar; 19(2):155-61. PubMed ID: 25578527 [TBL] [Abstract][Full Text] [Related]
5. Valproic acid plasma concentration decreases in a dose-independent manner following administration of meropenem: a retrospective study. Haroutiunian S; Ratz Y; Rabinovich B; Adam M; Hoffman A J Clin Pharmacol; 2009 Nov; 49(11):1363-9. PubMed ID: 19773524 [TBL] [Abstract][Full Text] [Related]
6. Influence of age and co-medication on the concentration and efficacy of valproic acid in Chinese epilepsy children. Wang Y; Hu W; Li Z Pak J Pharm Sci; 2020 Mar; 33(2):537-542. PubMed ID: 32276895 [TBL] [Abstract][Full Text] [Related]
7. Reduced valproic acid serum concentrations due to drug interactions with carbapenem antibiotics: overview of 6 cases. Park MK; Lim KS; Kim TE; Han HK; Yi SJ; Shin KH; Cho JY; Shin SG; Jang IJ; Yu KS Ther Drug Monit; 2012 Oct; 34(5):599-603. PubMed ID: 22929406 [TBL] [Abstract][Full Text] [Related]
8. Levetiracetam compared to valproic acid: plasma concentration levels, adverse effects and interactions in aneurysmal subarachnoid hemorrhage. Mink S; Muroi C; Seule M; Bjeljac M; Keller E Clin Neurol Neurosurg; 2011 Oct; 113(8):644-8. PubMed ID: 21703756 [TBL] [Abstract][Full Text] [Related]
9. The Effect of Different Carbapenem Antibiotics (Ertapenem, Imipenem/Cilastatin, and Meropenem) on Serum Valproic Acid Concentrations. Wu CC; Pai TY; Hsiao FY; Shen LJ; Wu FL Ther Drug Monit; 2016 Oct; 38(5):587-92. PubMed ID: 27322166 [TBL] [Abstract][Full Text] [Related]
10. A prospective study of drug-drug interaction between antiepileptic drugs and meropenem in patients in a tertiary hospital in China from January 2020 to March 2023. Yu Q; Zhan SH; Lu HQ; Zhao J; Jin Y Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):516-524. PubMed ID: 38305597 [TBL] [Abstract][Full Text] [Related]
11. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy. Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265 [TBL] [Abstract][Full Text] [Related]
12. Effect of meropenem on disposition kinetics of valproate and its metabolites in rabbits. Yokogawa K; Iwashita S; Kubota A; Sasaki Y; Ishizaki J; Kawahara M; Matsushita R; Kimura K; Ichimura F; Miyamoto K Pharm Res; 2001 Sep; 18(9):1320-6. PubMed ID: 11683247 [TBL] [Abstract][Full Text] [Related]
13. Influence of age and co-medication on the steady-state pharmacokinetics of valproic acid in Tunisian patients with epilepsy. Ben Mahmoud L; Hakim A; Ghozzi H; Atheymen R; Sahnoun Z; Zeghal K Rev Neurol (Paris); 2017 Mar; 173(3):159-163. PubMed ID: 28320517 [TBL] [Abstract][Full Text] [Related]
14. Improved seizure control by alternating therapy of levetiracetam and valproate in epileptic rats. van Vliet EA; Edelbroek PM; Gorter JA Epilepsia; 2010 Mar; 51(3):362-70. PubMed ID: 19674045 [TBL] [Abstract][Full Text] [Related]
15. Early post-traumatic seizures are associated with valproic acid plasma concentrations and UGT1A6/CYP2C9 genetic polymorphisms in patients with severe traumatic brain injury. Sun Y; Yu J; Yuan Q; Wu X; Wu X; Hu J Scand J Trauma Resusc Emerg Med; 2017 Aug; 25(1):85. PubMed ID: 28841884 [TBL] [Abstract][Full Text] [Related]
16. Factors Influencing Sodium Valproate Serum Concentrations in Patients with Epilepsy Based on Logistic Regression Analysis. Lan X; Mo K; Nong L; He Y; Sun Y Med Sci Monit; 2021 Nov; 27():e934275. PubMed ID: 34776507 [TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy. Mei S; Feng W; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F Seizure; 2017 Oct; 51():22-26. PubMed ID: 28763744 [TBL] [Abstract][Full Text] [Related]
18. Effect of concomitant administration of meropenem and valproic acid in an elderly Chinese patient. Gu J; Huang Y Am J Geriatr Pharmacother; 2009 Feb; 7(1):26-33. PubMed ID: 19281938 [TBL] [Abstract][Full Text] [Related]
19. Epileptic seizures caused by low valproic acid levels from an interaction with meropenem. Fudio S; Carcas A; Piñana E; Ortega R J Clin Pharm Ther; 2006 Aug; 31(4):393-6. PubMed ID: 16882111 [TBL] [Abstract][Full Text] [Related]
20. Effects of UGT1A6 and GABRA1 on Standardized Valproic Acid Plasma Concentrations and Treatment Effect in Children With Epilepsy in China. Feng W; Mei S; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F Ther Drug Monit; 2016 Dec; 38(6):738-743. PubMed ID: 27855134 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]